Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E27.42 EPS (ttm)1.49 Insider Own0.05% Shs Outstand5.56B Perf Week11.48%
Market Cap222.58B Forward P/E14.18 EPS next Y2.88 Insider Trans-6.06% Shs Float5.55B Perf Month18.83%
Income8.36B PEG- EPS next Q0.48 Inst Own70.20% Short Float1.20% Perf Quarter15.73%
Sales48.65B P/S4.58 EPS this Y62.30% Inst Trans-2.39% Short Ratio1.86 Perf Half Y19.56%
Book/sh11.74 P/B3.48 EPS next Y1.55% ROA5.00% Target Price41.78 Perf Year13.15%
Cash/sh1.92 P/C21.20 EPS next 5Y-1.00% ROE13.50% 52W Range26.42 - 41.41 Perf YTD9.88%
Dividend1.52 P/FCF106.50 EPS past 5Y14.70% ROI14.70% 52W High-1.91% Beta0.66
Dividend %3.73% Quick Ratio1.10 Sales past 5Y0.90% Gross Margin80.10% 52W Low53.74% ATR1.31
Employees88300 Current Ratio1.40 Sales Q/Q-4.30% Oper. Margin13.30% RSI (14)73.92 Volatility2.41% 3.06%
OptionableYes Debt/Eq0.97 EPS Q/Q-71.30% Profit Margin17.90% Rel Volume2.49 Prev Close40.80
ShortableYes LT Debt/Eq0.76 EarningsOct 27 BMO Payout95.80% Avg Volume35.73M Price40.62
Recom2.60 SMA2010.85% SMA5014.41% SMA20018.59% Volume15,722,390 Change-0.44%
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Dec-03-20 09:43AM  
09:42AM  
09:30AM  
09:28AM  
09:14AM  
09:04AM  
09:00AM  
08:55AM  
08:24AM  
07:55AM  
07:41AM  
07:38AM  
06:44AM  
06:40AM  
06:38AM  
06:30AM  
06:25AM  
05:16AM  
04:30AM  
03:35AM  
Dec-02-20 06:24PM  
06:14PM  
05:54PM  
05:51PM  
05:43PM  
05:20PM  
04:51PM  
04:28PM  
04:24PM  
04:11PM  
04:06PM  
04:05PM  
04:01PM  
03:24PM  
03:05PM  
03:05PM  
03:04PM  
03:04PM  
02:35PM  
02:21PM  
01:15PM  
01:14PM  
01:04PM  
12:56PM  
12:41PM  
12:16PM  
11:51AM  
11:17AM  
11:03AM  
10:50AM  
10:47AM  
10:44AM  
10:19AM  
09:58AM  
09:55AM  
09:45AM  
09:44AM  
09:23AM  
09:20AM  
09:17AM  
09:17AM  
09:08AM  
08:58AM  
08:50AM  
08:49AM  
08:48AM  
08:18AM  
08:09AM  
07:58AM  
07:56AM  
07:50AM  
07:45AM  
07:35AM  
07:30AM  
07:26AM  
07:19AM  
07:16AM  
07:10AM  
06:56AM  
06:34AM  
06:18AM  
06:08AM  
06:08AM  
06:07AM  
05:27AM  
05:04AM  
04:43AM  
04:20AM  
03:32AM  
03:13AM  
02:58AM  
02:36AM  
02:05AM  
02:00AM  
Dec-01-20 09:19PM  
07:00PM  
06:01PM  
05:59PM  
05:49PM  
05:20PM  
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; a drug discovery collaboration with Sosei Group Corporation; and collaboration with LianBio. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5513,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM
GOETTLER MICHAELGroup PresidentFeb 28Option Exercise27.3722,852625,45953,036Mar 03 12:54 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3715,996437,81187,956Mar 03 12:54 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3738,8481,063,270172,542Mar 03 12:54 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 28Option Exercise27.3737,9341,038,254140,256Mar 03 12:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 28Option Exercise27.3717,824487,84330,045Mar 03 12:54 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.3791,4082,501,837222,496Mar 03 12:55 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37100,5482,751,999504,427Mar 03 12:55 PM
BOURLA ALBERTChairman & CEOFeb 28Option Exercise27.3733,135906,905232,888Mar 03 12:49 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3727,422750,540140,744Mar 03 12:49 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37173,6754,753,485556,084Mar 03 12:49 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise34.59144,9285,013,060503,738Feb 28 07:32 PM
ROGERS DAWNExecutive Vice PresidentFeb 26Option Exercise34.5915,097522,20524,995Feb 28 07:28 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise34.5972,4642,506,530180,558Feb 28 07:28 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise34.5933,4141,155,79093,211Feb 28 07:24 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise34.5988,5673,063,533189,936Feb 28 07:25 PM
GOETTLER MICHAELGroup PresidentFeb 26Option Exercise34.5920,129696,26245,557Feb 28 07:22 PM
Hwang AngelaGroup PresidentFeb 26Option Exercise34.5914,493501,31332,470Feb 28 07:22 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise34.59144,9285,013,060482,320Feb 28 07:19 PM
BOURLA ALBERTChairman & CEOFeb 26Option Exercise34.5988,5673,063,533274,479Feb 28 07:16 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise34.5924,155835,521131,196Feb 28 07:15 PM
Gottlieb ScottDirectorJan 30Buy37.001,00036,9974,000Jan 31 08:06 AM